[
  {
    "variant_string_id": "αS_UnknownMutation1",
    "functional_evidence": {
      "study_summary": "The study investigates three αS point mutations linked to early-onset autosomal dominant Parkinsonism. It focuses on their structural and functional effects on αS, particularly in the context of aggregation and pathogenicity.",
      "ACMG_steps": [
        {
          "step": "Step 1: Disease Association",
          "details": "The three αS mutations are explicitly associated with Parkinson's disease, meeting the criteria for disease relevance."
        },
        {
          "step": "Step 2: Functional Analysis",
          "details": "The study uses biochemical and biophysical methods to analyze the mutations' impact on αS, including aggregation propensity and structural changes."
        },
        {
          "step": "Step 3: Statistical Analysis",
          "details": "The study does not report OddsPath calculations, but it provides comparative data on the mutations' effects relative to wild-type αS."
        }
      ],
      "interpretation": {
        "functional_evidence_strength": "Max PS3_supporting",
        "reasoning": "The study demonstrates functional effects of the mutations but lacks OddsPath calculations or variant controls. The evidence is supportive but not conclusive."
      }
    }
  },
  {
    "variant_string_id": "αS_UnknownMutation2",
    "functional_evidence": {
      "study_summary": "Similar to the first mutation, this variant is analyzed for its role in αS aggregation and its contribution to Parkinson's pathogenesis.",
      "ACMG_steps": [
        {
          "step": "Step 1: Disease Association",
          "details": "The mutation is linked to Parkinson's disease as per the study's context."
        },
        {
          "step": "Step 2: Functional Analysis",
          "details": "The study identifies altered structural properties and increased aggregation potential in this mutation."
        },
        {
          "step": "Step 3: Statistical Analysis",
          "details": "No OddsPath values are reported, but the mutation's effects are compared to controls."
        }
      ],
      "interpretation": {
        "functional_evidence_strength": "Max PS3_supporting",
        "reasoning": "Functional data supports pathogenicity, but without OddsPath or variant controls, the evidence is classified as supportive."
      }
    }
  },
  {
    "variant_string_id": "αS_UnknownMutation3",
    "functional_evidence": {
      "study_summary": "The third mutation is examined for its impact on αS function, including interactions with other proteins and cellular toxicity.",
      "ACMG_steps": [
        {
          "step": "Step 1: Disease Association",
          "details": "The mutation is associated with Parkinson's disease based on the study's focus."
        },
        {
          "step": "Step 2: Functional Analysis",
          "details": "The study highlights altered protein interactions and potential neurotoxicity linked to this mutation."
        },
        {
          "step": "Step 3: Statistical Analysis",
          "details": "No OddsPath values are provided, but the mutation's effects are contextualized within the study's framework."
        }
      ],
      "interpretation": {
        "functional_evidence_strength": "Max PS3_supporting",
        "reasoning": "The mutation's functional effects are reported, but the absence of statistical metrics or controls limits the strength of the evidence."
      }
    }
  }
]